✦ LIBER ✦

P.2.c.003 A placebo-controlled study of EB-1010, a novel triple re-uptake inhibitor, in patients with major depressive disorder

✍ Scribed by P. Tran; M. Bradshaw; A. McKinney; F. Bymaster; P. Skolnick; P. Czobor; N. Huang; J. Manthis; M. Fava

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of the novel t

✍ Pierre Tran; Phil Skolnick; Pal Czobor; N.Y. Huang; Mark Bradshaw; Anthony McKin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 297 KB

An open-label study of duloxetine hydroc

✍ Berk, M.; du Plessis, A.D.; Birkett, M.; Richardt, D. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 277 KB

P.2.c.040 A randomised, double-blind, pl

✍ F. Artigas; M. Dragheim; H. Loft; V. Perez; E. Álvarez 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Concerns about data reporting and interp

✍ David M. Marks; Jonathan S. Abramowitz; Glen I. Spielmans 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 84 KB

P.2.c.023 Discerning the etiology of sex

✍ Tufan, A.; Ozten, E.; Isik, S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 194 KB

P.2.c.038 Duloxetine versus placebo in p

✍ T.M. Myers-Oakes; M.E. Thase; A.L. Meyers; J. Ahl; A. Prakash; L.B. Marangell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 207 KB